Nina Tardif

3PUBLICATIONS
7CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 28, 2022
The AhR-SRC axis as a therapeutic vulnerability in BRAFi-resistant melanoma.

Anaïs Paris, Nina Tardif, Francesca M Baietti

|Jan 16, 2021
AhR and Cancer: From Gene Profiling to Targeted Therapy.

Anaïs Paris, Nina Tardif, Marie-Dominique Galibert

|Jul 26, 2020
Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors.

Héloïse M Leclair, Nina Tardif, Anaïs Paris

Pageof 1